In vitro diagnostics (IVD) are tests done on samples that have been taken from the human body, such as blood or tissue. IVDs can detect diseases or other conditions and can be used to monitor a person’s overall health to help cure, treat or prevent diseases.

IVDs may also be used in precision medicine to identify patients who are likely to benefit from specific treatments or therapies. These IVDs can include next-generation sequencing tests, which scan a person’s DNA to detect genomic variations. Some tests are used in laboratory or other health professional settings, while other tests are for consumers to use at home.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

According to GlobalData, the global IVD market size was valued at $84.27bn last year and is projected to decline at a compound annual growth rate (CAGR) of 4% from 2022 to 2030. This decline can be attributed to the decreasing use of IVD owing to the fall in testing as the pandemic slows down. However, the category of oncology within the IVD market is projected to grow at a CAGR of 6% between now and 2030. The development of automated IVD systems for laboratories and hospitals to provide efficient, accurate and error-free diagnoses is expected to fuel the market growth. The rising number of IVD products being launched by key players is also fueling the growth of the oncology IVD market. IVD products with molecular diagnostic capabilities deliver effective and accurate results.

The top key players in the IVD market are Siemens Healthcare, Johnson & Johnson, Becton Dickinson, Abbott Laboratories, Roche Diagnostics, Beckman Coulter, Thermo Scientific, Cobas, Caprion, Merck Millipore, Aptiv Solution, Danaher Corporation, bioMerieux, Bio-Rad Laboratories, Ortho Clinical Diagnostics, Sysmex Corporation, Mindray, Shanghai Kehua Bioengineering, BioSino Biotechnology, Beijing Leadman Biochemistry, and DAAN Gene.